1. Home
  2. DMAC vs IHRT Comparison

DMAC vs IHRT Comparison

Compare DMAC & IHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DMAC
  • IHRT
  • Stock Information
  • Founded
  • DMAC 2000
  • IHRT N/A
  • Country
  • DMAC United States
  • IHRT United States
  • Employees
  • DMAC N/A
  • IHRT N/A
  • Industry
  • DMAC Biotechnology: Pharmaceutical Preparations
  • IHRT Broadcasting
  • Sector
  • DMAC Health Care
  • IHRT Consumer Discretionary
  • Exchange
  • DMAC Nasdaq
  • IHRT Nasdaq
  • Market Cap
  • DMAC 274.1M
  • IHRT 303.0M
  • IPO Year
  • DMAC N/A
  • IHRT 2019
  • Fundamental
  • Price
  • DMAC $4.82
  • IHRT $1.88
  • Analyst Decision
  • DMAC Strong Buy
  • IHRT Buy
  • Analyst Count
  • DMAC 3
  • IHRT 3
  • Target Price
  • DMAC $7.00
  • IHRT $3.00
  • AVG Volume (30 Days)
  • DMAC 118.6K
  • IHRT 1.0M
  • Earning Date
  • DMAC 11-13-2024
  • IHRT 11-07-2024
  • Dividend Yield
  • DMAC N/A
  • IHRT N/A
  • EPS Growth
  • DMAC N/A
  • IHRT N/A
  • EPS
  • DMAC N/A
  • IHRT N/A
  • Revenue
  • DMAC N/A
  • IHRT $3,803,046,000.00
  • Revenue This Year
  • DMAC N/A
  • IHRT $6.16
  • Revenue Next Year
  • DMAC N/A
  • IHRT N/A
  • P/E Ratio
  • DMAC N/A
  • IHRT N/A
  • Revenue Growth
  • DMAC N/A
  • IHRT N/A
  • 52 Week Low
  • DMAC $2.14
  • IHRT $0.81
  • 52 Week High
  • DMAC $6.41
  • IHRT $3.04
  • Technical
  • Relative Strength Index (RSI)
  • DMAC 47.28
  • IHRT 35.07
  • Support Level
  • DMAC $5.05
  • IHRT $2.26
  • Resistance Level
  • DMAC $5.74
  • IHRT $2.20
  • Average True Range (ATR)
  • DMAC 0.37
  • IHRT 0.18
  • MACD
  • DMAC -0.08
  • IHRT -0.08
  • Stochastic Oscillator
  • DMAC 28.10
  • IHRT 5.14

About DMAC DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

About IHRT iHeartMedia Inc.

iHeartMedia Inc is a United States-based diversified media and entertainment company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.

Share on Social Networks: